WallStSmart

American Healthcare REIT, Inc. (AHR)vsChiron Real Estate Inc. (XRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American Healthcare REIT, Inc. generates 1465% more annual revenue ($2.37B vs $151.53M). AHR leads profitability with a 4.2% profit margin vs -5.1%. AHR earns a higher WallStSmart Score of 48/100 (D+).

AHR

Hold

48

out of 100

Grade: D+

Growth: 8.7Profit: 4.5Value: 4.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.95

XRN

Hold

45

out of 100

Grade: D+

Growth: 5.3Profit: 4.0Value: 4.0Quality: 3.5
Piotroski: 4/9Altman Z: -0.36

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHR3 strengths · Avg: 8.7/10
EPS GrowthGrowth
306.2%10/10

Earnings expanding 306.2% YoY

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
20.9%8/10

Revenue surging 20.9% year-over-year

XRN2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
23.4%8/10

Strong operational efficiency at 23.4%

Areas to Watch

AHR4 concerns · Avg: 2.8/10
Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
78.8x2/10

Premium valuation, high expectations priced in

XRN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$533.09M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.363/10

Elevated debt levels

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : AHR

The strongest argument for AHR centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 20.9% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on Price/Book, Operating Margin. Revenue growth of 10.1% demonstrates continued momentum.

Bear Case : AHR

The primary concerns for AHR are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 78.8x leaves little room for execution misses. Thin 4.2% margins leave little buffer for downturns.

Bear Case : XRN

The primary concerns for XRN are EPS Growth, Market Cap, Debt/Equity.

Key Dynamics to Monitor

AHR profiles as a growth stock while XRN is a turnaround play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.14 — expect wider price swings.

AHR is growing revenue faster at 20.9% — sustainability is the question.

AHR generates stronger free cash flow (50M), providing more financial flexibility.

Bottom Line

AHR scores higher overall (48/100 vs 45/100) and 20.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Healthcare REIT, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

American Healthcare REIT, Inc. is a leading real estate investment trust (REIT) dedicated to acquiring and managing a diversified portfolio of high-quality healthcare facilities throughout the United States, encompassing senior housing, skilled nursing, and medical office properties. By partnering with experienced operators in the healthcare sector, the company aims to deliver stable cash flows and sustainable growth while prioritizing the enhancement of care for residents and patients. Given the ongoing expansion of the healthcare real estate market, American Healthcare REIT stands out as a compelling investment opportunity for institutional investors seeking exposure to a robust and essential sector of the economy.

Visit Website →

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?